# PharmaCyte Biotech, Inc.: Form 8-K, filed Nov 24, 2023

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: 8-K
- Filed: 2023-11-24
- Accepted by EDGAR: Nov 24, 2023, 21:00 ET
- Period: 2023-11-20
- Accession: 0001683168-23-008446
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000168316823008446/pharmacyte_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000168316823008446/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000168316823008446/pharmacyte_8k.htm

Filed Nov 24, 2023.
Source: SEC EDGAR, the filing index for accession 0001683168-23-008446. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.